Cartesian Therapeutics Inc. (RNAC) — Free Cash Flow Generation Index

Latest as of September 2024: 0.55x

Cartesian Therapeutics Inc. (RNAC) has a Free Cash Flow Generation Index of 0.55x as of September 2024. Free cash flow of $7.49 Million represents 1% of operating cash flow ($13.69 Million). Read RNAC liabilities breakdown for a breakdown of total debt and financial obligations.

FCF Generation Index

0.55x
Free Cash Flow / Operating CF

Free Cash Flow

$7.49 Million
USD

Operating Cash Flow

$13.69 Million
USD

Capital Expenditures

$6.20 Million
USD

Cartesian Therapeutics Inc. Free Cash Flow Generation Index (2020–2020)

Historical FCF Generation Index trend for Cartesian Therapeutics Inc. across 1 annual periods. Explore RNAC capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Cartesian Therapeutics Inc. (2020–2020)

Year-by-year Free Cash Flow Generation Index for Cartesian Therapeutics Inc.. For the full company profile including market capitalisation, see how much is Cartesian Therapeutics Inc. worth.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.98x $34.07 Million $34.88 Million $815.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).